Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Rh-Catalyzed domino synthesis of 4-hydroxy-3-methylcoumarins via branch-selective hydroacylation.

Rao MLN, Ramakrishna BS, Nand S.

Org Biomol Chem. 2019 Oct 30;17(42):9275-9279. doi: 10.1039/c9ob01972c.

PMID:
31621744
2.

Rh-Catalyzed Deformylative Coupling of Salicylaldehydes with Acrylates and Acrylamides.

Rao MLN, Ramakrishna BS.

J Org Chem. 2019 May 3;84(9):5677-5683. doi: 10.1021/acs.joc.9b00602. Epub 2019 Apr 9.

PMID:
30964676
3.
4.

Rapid regio- and multi-coupling reactivity of 2,3-dibromobenzofurans with atom-economic triarylbismuths under palladium catalysis.

Rao ML, Talode JB, Murty VN.

Beilstein J Org Chem. 2016 Sep 22;12:2065-2076. eCollection 2016.

5.
6.

Early improvement and serum concentrations of citalopram to predict antidepressant drug response of patients with major depression.

Ostad Haji E, Tadic A, Wagner S, Dragivevic A, Müller MJ, Boland K, Rao ML, Fric M, Laux G, Hiemke C.

Pharmacopsychiatry. 2013 Nov;46(7):261-6. doi: 10.1055/s-0033-1354370. Epub 2013 Sep 24.

PMID:
24065567
7.

Potential cost-effectiveness of therapeutic drug monitoring for depressed patients treated with citalopram.

Ostad Haji E, Mann K, Dragicevic A, Müller MJ, Boland K, Rao ML, Fric M, Laux G, Hiemke C.

Ther Drug Monit. 2013 Jun;35(3):396-401. doi: 10.1097/FTD.0b013e3182885d9d.

PMID:
23666582
8.

Studies on antimicrobial efficacy of medicinal tuberous shrub Talinum cuneifolium.

Savithramma N, Ankanna S, Rao ML, Saradvathi J.

J Environ Biol. 2012 Jul;33(4):775-80.

PMID:
23360007
9.

Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010.

Wang YJ, Zhang SM, Zhang L, Wang CX, Dong Q, Gao S, Huang RX, Huang YN, Lv CZ, Liu M, Qin HQ, Rao ML, Xiao Y, Xu YM, Yang ZH, Wang YJ, Wang CX, Wang JZ, Wang WZ, Wang J, Wang WJ, Wu J, Wu SP, Zeng JS, Zhang SM, Zhang L, Zhao XQ, Zhong LY.

CNS Neurosci Ther. 2012 Feb;18(2):93-101. doi: 10.1111/j.1755-5949.2011.00290.x. No abstract available.

10.

The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.

Dreimüller N, Tadić A, Dragicevic A, Boland K, Bondy B, Lieb K, Laux G, Maier W, Müller MJ, Rao ML, Rietschel M, Röschke J, Zill P, Hiemke C.

Pharmacopsychiatry. 2012 May;45(3):108-13. doi: 10.1055/s-0031-1291347. Epub 2011 Nov 15.

PMID:
22086748
11.

Transition-metal catalyzed C-C bond formation using organobismuth compounds.

Shimada S, Rao ML.

Top Curr Chem. 2012;311:199-228. doi: 10.1007/128_2011_202.

PMID:
21809192
12.

Association between citalopram serum levels and clinical improvement of patients with major depression.

Ostad Haji E, Tadić A, Wagner S, Dragicevic A, Müller MJ, Boland K, Rao ML, Fric M, Laux G, Hiemke C.

J Clin Psychopharmacol. 2011 Jun;31(3):281-6. doi: 10.1097/JCP.0b013e318218f503.

PMID:
21508853
13.

Pd-catalyzed domino synthesis of internal alkynes using triarylbismuths as multicoupling organometallic nucleophiles.

Rao ML, Jadhav DN, Dasgupta P.

Org Lett. 2010 May 7;12(9):2048-51. doi: 10.1021/ol1004164.

PMID:
20377270
14.

[Extraoral reduction of temporomandibular joint dislocation].

Rao ML, Lin CS, Yang AY, Guan QQ, Huang S.

Zhongguo Gu Shang. 2009 Mar;22(3):211. Chinese. No abstract available.

PMID:
19366107
15.
16.

Is MAO-B activity in platelets associated with the occurrence of suicidality and behavioural personality traits in depressed patients?

Lewitzka U, Müller-Oerlinghausen B, Felber W, Brunner J, Hawellek B, Rujescu D, Ising M, Lauterbach E, Broocks A, Bondy B, Rao ML, Frahnert C, Heuser I, Hohagen F, Maier W, Bronisch T.

Acta Psychiatr Scand. 2008 Jan;117(1):41-9. Epub 2007 Nov 19.

PMID:
18028252
17.

The defining role of structure (including epitaxy) in the plausibility of homeopathy.

Rao ML, Roy R, Bell IR, Hoover R.

Homeopathy. 2007 Jul;96(3):175-82. Erratum in: Homeopathy. 2007 Oct;96(4):292.

PMID:
17678814
18.

[Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].

Baumann P, Hiemke C, Ulrich S, Eckermann G, Kuss HL, Laux G, Müller-Oerlingenhausen B, Rao ML, Riederer P, Zernig G; AGNP-TDM; Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) - Therapeutic Drug Monitoring (TDM).

Rev Med Suisse. 2006 May 24;2(67):1413-8, 1420-2, 1424-6. Review. French.

PMID:
16786958
19.

Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior.

Lauterbach E, Brunner J, Hawellek B, Lewitzka U, Ising M, Bondy B, Rao ML, Frahnert C, Rujescu D, Müller-Oerlinghausen B, Schley J, Heuser I, Maier W, Hohagen F, Felber W, Bronisch T.

J Affect Disord. 2006 Mar;91(1):57-62. Epub 2006 Jan 18.

PMID:
16412522
20.

Subtype hypertension and risk of stroke in middle-aged and older Chinese: a 10-year follow-up study.

Fang XH, Zhang XH, Yang QD, Dai XY, Su FZ, Rao ML, Wu SP, Du XL, Wang WZ, Li SC.

Stroke. 2006 Jan;37(1):38-43. Epub 2005 Nov 23.

PMID:
16306467
21.

The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Baumann P, Ulrich S, Eckermann G, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Hiemke C; Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsyhiatrie - Therapeutic Drug Monitoring group.

Dialogues Clin Neurosci. 2005;7(3):231-47.

22.

A multicenter study about Neurobiology of Suicidal Behavior: design, development, and preliminary results.

Bronisch T, Brunner J, Bondy B, Rujescu D, Bishof G, Heuser I, Müller-Oerlinghausen B, Hawellek B, Maier W, Rao ML, Felber W, Lewitzka U, Oehler J, Broocks A, Hohagen F, Lauterbach E.

Arch Suicide Res. 2005;9(1):19-26.

PMID:
16040576
23.

Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.

Grasmäder K, Verwohlt PL, Kühn KU, Frahnert C, Hiemke C, Dragicevic A, von Widdern O, Zobel A, Maier W, Rao ML.

Pharmacopsychiatry. 2005 May;38(3):113-7.

PMID:
15902580
24.

An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India.

Sampath G, Reddy SV, Rao ML, Rao YU, Palaniappan C.

Vaccine. 2005 Jan 4;23(7):897-900.

PMID:
15603890
25.

Magnetism and magnetotransport in sonochemically-prepared amorphous Co(100-x)Pt(x) nanoalloys.

Rao ML, Manoharan SS, Elefant D, Schneider CM.

J Nanosci Nanotechnol. 2004 Sep;4(7):722-5.

PMID:
15570952
26.

Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.

Kühn KU, Joe AY, Meyer K, Reichmann K, Maier W, Rao ML, Reinhardt MJ, Biersack HJ, Quednow BB.

Pharmacopsychiatry. 2004 Nov;37(6):286-91.

PMID:
15551195
27.

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.

Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G; Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie.

Pharmacopsychiatry. 2004 Nov;37(6):243-65. Review.

PMID:
15551191
28.

Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.

Feuchtl A, Bagli M, Stephan R, Frahnert C, Kölsch H, Kühn KU, Rao ML.

Pharmacopsychiatry. 2004 Jul;37(4):180-8.

PMID:
15467976
29.

Population pharmacokinetic analysis of mirtazapine.

Grasmäder K, Verwohlt PL, Kühn KU, Dragicevic A, von Widdern O, Zobel A, Hiemke C, Rietschel M, Maier W, Jaehde U, Rao ML.

Eur J Clin Pharmacol. 2004 Sep;60(7):473-80.

PMID:
15289959
30.

SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.

Spell C, Kölsch H, Lütjohann D, Kerksiek A, Hentschel F, Damian M, von Bergmann K, Rao ML, Maier W, Heun R.

Dement Geriatr Cogn Disord. 2004;18(3-4):245-9. Epub 2004 Jul 29.

PMID:
15286454
31.

Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.

Baumann P, Hiemke C, Ulrich S, Gaertner I, Rao ML, Eckermann G, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Riederer P, Zernig G.

Ther Drug Monit. 2004 Apr;26(2):167-70.

PMID:
15228159
32.

Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.

Grasmäder K, Verwohlt PL, Rietschel M, Dragicevic A, Müller M, Hiemke C, Freymann N, Zobel A, Maier W, Rao ML.

Eur J Clin Pharmacol. 2004 Jul;60(5):329-36. Epub 2004 May 28.

PMID:
15168101
33.

Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease.

Kölsch H, Ptok U, Majores M, Schmitz S, Rao ML, Maier W, Heun R.

Psychiatr Genet. 2004 Jun;14(2):97-100.

PMID:
15167696
34.

Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease.

Brune S, Kölsch H, Ptok U, Majores M, Schulz A, Schlosser R, Rao ML, Maier W, Heun R.

J Neural Transm (Vienna). 2003 Sep;110(9):1041-50.

PMID:
12938026
35.

Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease.

Kölsch H, Ptok U, Mohamed I, Schmitz S, Rao ML, Maier W, Heun R.

Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):128-30.

PMID:
12898587
36.
37.

Polymorphism in the BACE gene influences the risk for Alzheimer's disease.

Kirschling CM, Kölsch H, Frahnert C, Rao ML, Maier W, Heun R.

Neuroreport. 2003 Jul 1;14(9):1243-6.

PMID:
12824768
38.

Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?

Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C.

Pharmacopsychiatry. 2003 May;36(3):98-104.

PMID:
12806567
39.

[Therapeutic drug monitoring of antidepressives--therapeutic and health economics advantages].

Grasmäder K, Lohmann PL, Kuss HJ, Laux G, Hiemke C, Rao ML.

Med Monatsschr Pharm. 2003 May;26(5):162-4. Review. German. No abstract available.

PMID:
12784507
40.

CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.

Lohmann PL, Bagli M, Krauss H, Müller DJ, Schulze TG, Fangerau H, Ludwig M, Barkow K, Held T, Heun R, Maier W, Rietschel M, Rao ML.

Pharmacopsychiatry. 2003 Mar-Apr;36(2):73-8.

PMID:
12734765
41.

5,6,7,12-tetrahydrodibenz[c,f][1,5]azabismocines: highly reactive and recoverable organobismuth reagents for cross-coupling reactions with aryl bromides.

Shimada S, Yamazaki O, Tanaka T, Rao ML, Suzuki Y, Tanaka M.

Angew Chem Int Ed Engl. 2003 Apr 25;42(16):1845-8. No abstract available. Erratum in: Angew Chem Int Ed Engl. 2003 Jun 23;42(24):2702.

PMID:
12722078
42.

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.

Bagli M, Papassotiropoulos A, Hampel H, Becker K, Jessen F, Bürger K, Ptok U, Rao ML, Möller HJ, Maier W, Heun R.

Eur Arch Psychiatry Clin Neurosci. 2003 Feb;253(1):44-8.

PMID:
12664314
43.

Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia.

Rao ML, Kölsch H.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:83-96. Review.

PMID:
12650683
44.

Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.

Ehl C, Kölsch H, Ptok U, Jessen F, Schmitz S, Frahnert C, Schlösser R, Rao ML, Maier W, Heun R.

Int J Mol Med. 2003 Feb;11(2):235-8.

PMID:
12525884
45.

Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.

Kühn KU, Quednow BB, Bagli M, Meyer K, Feuchtl A, Westheide J, Frahnert C, Maier W, Rao ML.

Pharmacopsychiatry. 2002 Nov;35(6):226-30.

PMID:
12518270
46.

Neuroprotective effects of estradiol-17beta: implications for psychiatric disorders.

Kölsch H, Rao ML.

Arch Womens Ment Health. 2002 Nov;5(3):105-10. Review.

PMID:
12510213
47.

Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.

Oades RD, Klimke A, Henning U, Rao ML.

Hum Psychopharmacol. 2002 Jan;17(1):15-27.

PMID:
12404703
48.

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.

Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R.

Mol Psychiatry. 2002;7(8):899-902.

49.

FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses.

von Bubnoff D, Matz H, Frahnert C, Rao ML, Hanau D, de la Salle H, Bieber T.

J Immunol. 2002 Aug 15;169(4):1810-6.

50.

Supplemental Content

Support Center